Our Company
Established in 2019, KO DA Pharmaceutical (Singapore) Pte Ltd is the Southeast Asian subsidiary of Ko Da Pharmaceutical Co., Ltd. (Taiwan). With over 40 years of manufacturing expertise, we are committed to advancing scientific Chinese medicine across the region by integrating traditional knowledge with modern innovation. We provide high-quality, standardized herbal solutions for healthcare professionals and wellness practitioners.
The parent company, Ko Da Pharmaceutical Co., Ltd., established in 1980, is a professional GMP-certified manufacturer of concentrated Chinese herbal medicines, located in the Pingzhen Industrial Park, Taoyuan, Taiwan. It is the only Chinese medicine manufacturer in Taiwan to hold three international certifications: ISO 9001, ISO/IEC 17025 TAF, and ISO 14064. The company specializes in the concentration, purification, and extraction of herbal ingredients, offering a wide range of products including scientific Chinese medicines, health supplements, herbal slices, and medicinal cuisine. Its products are widely sold across Taiwan and exported to 15 countries worldwide. With over 700 approved licenses for scientific Chinese medicines, Ko Da’s products are used in more than 80% of TCM (Traditional Chinese Medicine) hospitals and clinics in Taiwan.
Ko Da has established an in-house R&D center and pilot plant, offering one-stop development and manufacturing services from raw materials to finished products. It has also built a comprehensive traceability and quality management system, including Taiwan’s first “Herbal Ingredient Traceability Platform” that publicly discloses sourcing and testing information via QR codes. In addition, Ko Da developed the first “TCM Dispensing Verification System” in Taiwan, significantly improving dispensing accuracy and service quality in TCM clinics. Over the years, Ko Da has been recognized with numerous national quality awards and continues to drive the modernization and globalization of Chinese medicine through innovation and professionalism.
Our Vision
Our vision is to become a leading modern Chinese medicine brand in Southeast Asia by connecting the industry with clinical practice and academic exchange.
Our Mission
Our mission is to make Chinese medicine more scientific, accessible, and trusted globally.
GMP
Backed by Taiwan GMP-certified manufacturing & ISO-accredited labs
R&D
Premium herbal ingredients with full traceability and quality control
Clinical Collaboration
Strong collaboration with TCM practitioners for clinical and academic advancement
Our Commitment
In Singapore, we are more than just a supplier — we are a committed partner to TCM professionals.
We offer stable supply, technical support, and academic platforms to co-create new possibilities in healthcare.
Global Integration
Ko Da’s products are distributed in Singapore, Malaysia, Canada, the UK, and more.
We actively participate in international forums, academic programs, and regulatory expansion to bridge Chinese medicine with the global market.
Annual Corporate Awards & Certifications
-
Awarded ISO 9001:2000 International Quality Certification.
-
Received the National Biotechnology & Pharmaceutical Quality Award (Herbal Pharmaceutical Factory – Overall Competitiveness Category).
-
11th National Award of Outstanding SMEs by the Ministry of Economic.
-
Selected as E-Industry Demonstration Enterprise by the Department of Commerce, MOEA.
-
Awarded Innovation & Research Excellence SME Award by MOEA.
-
7th Industrial Technology Advancement Award (Manufacturing Excellence), MOEA.
-
Evergreen Enterprise Excellence Award – Corporate Contribution, Taoyuan County Government.
-
Excellence in Enterprise Management Mark by MOEA.
-
17th Industrial Technology Development Award – Outstanding Innovation Enterprise.
Certified in ISO 14064 Greenhouse Gas Inventory. -
Accredited ISO/IEC 17025 TAF Laboratory Certification
Certified by TFDA Pharmaceutical Laboratory Accreditation
Received Quality Team Award by CQS (Chinese Society for Quality) -
Awarded Outstanding SME Corporate Social Responsibility Award.
-
TTQS Bronze Award by Council of Labor Affairs.
-
Subsidized by MOEA to establish Herbal Traceability Platform
3rd Industrial Innovation Award by MOEA
23rd National Quality Award – Executive Yuan -
15th National Standardization Award by BSMI.
-
9th Taoyuan Excellent Enterprise Award – Innovation Excellence
-
Certified ISO 9001:2015
Received ISO Plus Award for Herbal Source Management -
Awarded Dun & Bradstreet SME Elite Award
-
TTQS Silver Award by Workforce Development Agency, MOL
AQM Excellence Case Award – New Application Category -
Awarded D&B SME Elite Award
Certified HALAL International Certification
5th Potential Mittelstand Award by MOEA
Awarded Low-Carbon Technology & Energy-Saving Recognition, Taoyuan -
Received D&B SME Elite Award for 4 consecutive years
SGS ISO Plus Award – Excellence in Change & Innovation Management. -
TTQS Silver Award.
-
Awarded D&B SME Elite Award for 6 consecutive years.
-
Passed ISO 50001:2018 Energy Management Certification with zero nonconformities.
Certified ISO 14064-1 Greenhouse Gas Inventory; selected as Low-Carbon Manufacturing Demonstration Team
Recognized in MOEA Accelerated Investment Program – Top 10 Benchmark Enterprises
Annual Milestones
-
Investment and factory preparation initiated by Pai Shou Pharmaceutical Factory.
-
Phase I factory construction completed and commenced operation.
-
Appointed Japanese pharmaceutical expert Mr. Hasegawa as Plant Director, responsible for product development and research.
-
Invited experts in medicine, pharmacy, and pharmacognosy to participate in product R&D; expanded Phase II GMP factory in response to the government’s GMP implementation.
-
Completion of Phase II GMP factory. Official establishment of Ko Da Pharmaceutical Co., Ltd., specializing in concentrated Chinese medicines.
-
Passed one of Taiwan’s first GMP software audits for Chinese medicine factories.
-
Certified by the government as a GMP-compliant Chinese medicine manufacturer; launched standardized scientific Chinese medicine products.
-
Completed Phase III expansion with warehouse building, integrating factory and office functions.
-
Entered overseas markets, exporting products to the UK and USA.
-
Invested NT$350 million to construct a biotechnology building, aligning with Taiwan’s “Root in Taiwan” policy.
-
Established the Food Division; launched functional health supplements.
-
Completed biotechnology building; established Cosmetics Division and R&D Center, becoming Taiwan’s first company integrating scientific Chinese medicine, health supplements, and cosmetics.
-
Selected by the Ministry of Economic Affairs as a model enterprise for digital transformation. Introduced ICP and GC testing equipment to develop testing for heavy metals, pesticide residues, and aflatoxins.
-
Established a New Product Development Committee dedicated to R&D.
-
Launched improvement initiatives; co-developed concentrated extraction machinery with equipment manufacturers. Promoted process specialist certification and multi-skilled workforce performance. Digitized production traceability with barcode-based sales tracking system.
-
Collaborated with vendors to develop ERP system. Promoted Chinese Medicine Dispensing Checking System (EBCS), expanding pharmacy services at Taichung Hospital, Taipei VGH, Kaohsiung VGH, Fengyuan Hospital, and Puli Veterans Hospital.
-
Established subsidiary Sweet Valley Biotech, expanding cosmetics and health supplement distribution channels.
-
Received MOEA funding to build the world’s first “Chinese Medicine Traceability Platform.”
-
Upgraded EBCS with patented light-guided cabinet system and sachet printing with prescription info.
-
Collaborated with Ministry of Health and Welfare Taoyuan Hospital’s TCM Department to implement EBCS. Partnered with Tung’s Taichung MetroHarbor Hospital TCM Department, establishing “Shang-Yi Wellness Hall” next to its pharmacy.
-
Formed overseas partnerships, officially entering the Hong Kong market.
-
Established first overseas subsidiary: Ko Da Pharmaceutical (Singapore) Pte Ltd.
-
Groundbreaking ceremony for new cGMP pharmaceutical plant.
-
Completion of new cGMP pharmaceutical plant.
English 
Chinese